Clinical Trial

Microbial Restoration in Inflammatory Bowel Diseases

Study acronym: MIRO II
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 26, 2025 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, two-centre, double-blind, parallel-arm, randomised, placebo-controlled trial evaluating the impact of FMT on patients with active Crohn's disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-07-18; most recent amendment 2025-02-23.
Status change: Not Yet Recruiting → Recruiting 2023-11-21
Trial Details
NCT Number NCT04970446
Lead Sponsor St Vincent's Hospital Melbourne
Collaborators: The Queen Elizabeth Hospital, BiomeBank Adelaide, The University of Queensland, Monash University
Conditions Fecal Microbiota Transplantation, Crohn Disease, Inflammatory Bowel Diseases, Microbiome
Enrollment 120 participants
Start Date 2022-05-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-26